Phase I study of mitoxantrone plus etoposide with multidrug blockade by SDZ PSC-833 in relapsed or refractory acute myelogenous leukemia

PURPOSE: Expression of the multidrug resistance gene (MDR1) p170 protein is frequent in leukemic blasts from patients with relapsed acute myelogenous leukemia (AML). A phase I study using the nonimmunosuppressive MDR1 blocker SDZ PSC-833 (PSC) in combination with mitoxantrone (MITO) and etoposide (VP) was performed. PATIENTS AND METHODS: Starting doses (LVL0) of MITO (3.25 mg/m2/d on days 1 and 3 to 6) and VP (210 mg/m2/d on days 1 and 3 to 5) were 40% of the maximal-tolerated dose (MTD) from a prior study. A 1.5-mg/kg loading dose of PSC was followed by a 120-hour continuous infusion of 10 mg/kg/d on days 2 to 6. Blood samples for PSC, MITO, and VP pharmacokinetics (PK) were taken on days 1 and 3, and samples for MDR1 expression were taken on day 0. RESULTS: Severe mucositis developed in all patients at LVL0; therefore, MITO and VP doses were reduced to 2.5 and 170 mg/m2 (LVL-1) for the next seven patients, and this dose proved to be MTD. All LVL0 and three LVL-1 patients had transient elevations in the serum bilirubin level to > or = 4 mg/dL. Serum creatinine level increased to greater than 2 mg/dL in one case. There were no other grade 3 or 4 nonhematologic toxicities observed. The peripheral blood was cleared of leukemia in three LVL0 and four LVL-1 patients. The marrow was cleared of leukemic cells in one LVL0 and five LVL-1 patients, and a significant reduction in marrow leukemic infiltrate was observed in eight of 10. No patient achieved complete remission (CR), and all died of progressive disease (n = 8) or infection (n = 2). MDR1 expression was detected by fluorescent-activated cell sorter (FACS) analysis in five of seven cases. An elevated MDR1 mRNA level was detected by quantitative polymerase chain reaction (Q-PCR) in six of eight cases studied. Clearing of leukemia cells from the marrow occurred in four of six MDR1-positive and one of three MDR1-negative patients. Despite the fact that LVL0 doses had to be reduced due to toxicity, coadministration of PSC did not produce a consistent effect on MITO PK; however, it did repeatedly lead to increased levels of VP in the serum. CONCLUSION: We conclude that PSC-MITO-VP is a tolerable regimen with antileukemic activity. Addition of PSC necessitated a 66% reduction in MITO and VP doses from a prior study without PSC.     

用迁移率和载流子浓度研究碲镉汞中的深能级

获得了一种研究碲镉汞深能级的方法。通过分析迁移率 载子浓度与温度的关系，可以得到关于深能级的重要依据。     

粉尘薄膜爆轰

与普通爆轰不同，粉尘薄膜爆轰波前氧化剂与燃料处于分离状态．由于激波作用下壁面燃料的注入才于壁面附近形成燃烧的粉尘云，燃烧释放的热使激波自持形成粉尘薄膜爆轰。本文在长2、8m，横截面20mm×20mm的方型水平激波管中对此类爆轰进行了实验研究．并根据作者建立的模型对其二维结构进行了数值模拟。     

Protruded lumbar intervertebral nucleus pulposus in a 12-year-old girl who recovered after nonsurgical treatment: a follow-up case report

Restless legs syndrome affects millions, but most healthcare providers don't know it exists. Its sleep-deprived victims are plagued by indescribable crawling sensations in their legs that occur at night and that are only relieved by moving the legs. Many home healthcare clients, already challenged by their primary illness, are also affected by the persistent symptoms of Restless Legs Syndrome. It is important that home care nurses learn about Restless Legs Syndrome-what it is, how to assess it, and what can be done about it.     

熔窑玻璃液流数值模拟的新发展

熔窑玻璃液流数值模拟的新发展赵国昌（清华大学核能技术设计研究院，１０００８４）ＮｅｗＤｅｖｅｌｏｐｍｅｎｔｏｆｔｈｅＮｕｍｅｒｉｃａｌＳｉｍｕｌａｔｉｏｎｆｏｒＦｌｏｗａｎｄＨｅａｔＴｒａｎｓｆｅｒｏｆＧｌａｓｓＭｅｌｔｉｎＴａｎｋＦｕｒｎａｃｅ￥Ｚ...     

逻辑程序的一种并行执行模型

本文基于静态相关性分析和动态调整相结合的方法，提出了一种逻辑程序的执行模型，它不仅开发了“与“并行，同进也开发了一定的“或“并行，从而有效地加速了逻辑程序的执行。     

浅色补强填充剂LEE白滑粉在合成橡胶中的应用

介绍了新型浅色补强填充剂ＬＥＥ白滑粉的组成、物化性质、加工特性、硫化胶性能及应用前景。     

重馏分油加氢脱氮反应动力学模型的研究

简要地介绍了一些典型的模型氮化物的ＨＤＮ反应规律。根据胜利ＶＧＯ在３７２２Ｂ催化剂上的大量ＨＤＮ实验数据，提出了如下的ＨＤＮ基本反应动力学方程：ｄＣＮｄｔ＝－ｋ１＋Ｋ＊ＣＮＣＮＰＨ２为了扩大上式的应用范围，详细分析了各种因素（如原料油种类和馏程及Ｈ２Ｓ等）对ＨＤＮ的影响，并开发了相应的经验关联式，从而得到了一个较完整的馏分油ＨＤＮ反应动力学模型。验证实验表明，该模型是成功的。     

用于钻水平井的低密度水包油乳化钻井液

针对任平1井水平钻井的特点,研制了一种低密度、高油水比的水包油乳化钻井液。考察了乳化剂、增粘剂和配制工艺对乳状液性能的影响,评定了钻井液性能,介绍了现场应用情况。该钻井液性能稳定,润滑性好,净化井眼的能力强,能满足水平段钻井的要求。